⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10619730 | 1.00 | — | — | |
| SCHEMBL3640067 | 0.98 | CHRM1 (0.48) | — | |
| SCHEMBL3637192 | 0.98 | CHRM1 (0.48) | — | |
| SCHEMBL2053946 | 0.86 | CA2 (0.50) | — | |
| SCHEMBL284704 | 0.84 | GPR84 (0.52) | — | |
| SCHEMBL15621929 | 0.84 | GPR84 (0.52) | — | |
| SCHEMBL15622058 | 0.84 | GPR84 (0.52) | — | |
| SCHEMBL17065011 | 0.82 | GPR84 (0.55) | — | |
| SCHEMBL4565528 | 0.82 | GPR84 (0.55) | — | |
| SCHEMBL10593068 | 0.82 | GPR84 (0.55) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 311 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240238230-A1 | METHODS OF MODULATION OF BRANCHED CHAIN ACIDS AND USES THEREOF | BAYLOR COLLEGE OF MEDICINE | 2024-07-18 | — | — | US | claimed |
| US-11786494-B2 | Methods of modulation of branched chain acids and uses thereof | BAYLOR COLLEGE OF MEDICINE (US) | 2023-10-17 | — | — | US | claimed |
| US-20210349103-A1 | METABOLIC BIOMARKERS OF NAFLD/NASH AND RELATED DISEASE PHENOTYPES AND METHODS OF USING SAME | DUKE UNIVERSITY | 2021-11-11 | — | — | US | claimed |
| US-20200147016-A1 | METHODS OF MODULATION OF BRANCHED CHAIN ACIDS AND USES THEREOF | ACER THERAPEUTICS INC. | 2020-05-14 | — | — | US | claimed |
| CN-110520537-A | Method for generating methyl methacrylate | LUCITE INT UK LTD | 2019-11-29 | — | — | CN | claimed |
| US-20190151268-A1 | METHODS OF MODULATION OF BRANCHED CHAIN ACIDS AND USES THEREOF | ACER THERAPEUTICS INC. | 2019-05-23 | — | — | US | claimed |
| US-10113190-B2 | Method for producing L-leucine, L-valine, L-isoleucine, α-ketoisovalerate, α-keto-beta-methylvalerate, or α-ketoisocaproate using recombinant Corynebacteria that contain the ilvBN operon which can be induced by propionate | EVONIK DEGUSSA GMBH (DE) | 2018-10-30 | — | — | US | claimed |
| EP-3383379-A1 | COCOA POLYPHENOLS AND SOLUBLE DIETARY FIBER FOR USE IN THE TREATMENT OR PREVENTION DISORDERS ASSOCIATED WITH AN ABOVE-NORMAL NUMBER OF GRANULOCYTES IN A TISSUE | Nestec S.A. (CH) | 2018-10-10 | — | — | EP | claimed |
| US-20170312238-A1 | METHODS OF MODULATION OF BRANCHED CHAIN ACIDS AND USES THEREOF | ACER THERAPEUTICS INC. | 2017-11-02 | — | — | US | claimed |
| US-9737499-B2 | Methods of modulation of branched chain acids and uses thereof | BAYLOR COLLEGE OF MEDICINE (US) | 2017-08-22 | — | — | US | claimed |
| WO-2014001064-A1 | CLAY-COMPATIBLE ADDITIVE FOR CONSTRUCTION CHEMICALS | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2014-01-03 | — | — | WO | claimed |
| US-20120220661-A1 | METHODS OF MODULATION OF BRANCHED CHAIN ACIDS AND USES THEREOF | BAYLOR COLLEGE OF MEDICINE (US) | 2012-08-30 | — | — | US | claimed |
| EP-2456304-A1 | METHODS OF MODULATION OF BRANCHED CHAIN ACIDS AND USES THEREOF | Baylor College Of Medicine (US) | 2012-05-30 | — | — | EP | claimed |
| US-20120065428-A1 | METHOD FOR THE PREPARATION OF 2-KETO CARBOXYLIC ACID | EVONIK DEGUSSA GMBH (DE) | 2012-03-15 | — | — | US | claimed |
| WO-2011011781-A1 | METHODS OF MODULATION OF BRANCHED CHAIN ACIDS AND USES THEREOF | BAYLOR COLLEGE OF MEDICINE (US) | 2011-01-27 | — | — | WO | claimed |
| CN-1643154-A | Process for preparing chiral aromatic a-hydroxyketones using a 2-hydroxy-3-oxoacid synthase | UNIV BEN GURION (IL) | 2005-07-20 | — | — | CN | claimed |
| US-20020076393-A1 | Method for stimulation of defensin production | MAGAININ PHARMACEUTICALS, INC. | 2002-06-20 | — | — | US | claimed |
| WO-2001068085-A1 | A METHOD FOR STIMULATION OF DEFENSIN PRODUCTION | GENAERA CORPORATION (US) | 2001-09-20 | — | — | WO | claimed |
| EP-1093364-A1 | A METHOD FOR STIMULATION OF DEFENSIN PRODUCTION BY EXPOSURE TO ISOLEUCIN | MAGAININ PHARMACEUTICALS INC. (US) | 2001-04-25 | — | — | EP | claimed |
| WO-1999059574-A1 | A METHOD FOR STIMULATION OF DEFENSIN PRODUCTION BY EXPOSURE TO ISOLEUCIN | MAGAININ PHARMACEUTICALS, INC. (US) | 1999-11-25 | — | — | WO | claimed |